Abiopharma

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Steel Dynamics Provides Second Quarter 2026 Earnings Guidance

Venture Global and EnBW Announce New LNG Purchase Agreements

Nucor Announces Guidance for the Second Quarter of 2026 Earnings

Publication relating to transparency notifications

Franklin Covey to Report Third Quarter Fiscal 2026 Results

Legend Biotech Corporation Announces Proposed Public Offering

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

North Dallas Bank & Trust Co. Declares Regular Dividend

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)